• Kellamity@sh.itjust.works
    link
    fedilink
    arrow-up
    38
    ·
    edit-2
    7 months ago

    It’s very debatable if trump’s EO would have capped the price of Insulin or Epipens in a meaningful way - and its factually wrong that it was the same cap and legislation that Biden put into place.

    Trump’s EO meant that Federally Qualified Health Centers would have to offer Insulin and Epinephrine to “Low Income Individuals” without health insurance "at the discounted price paid by the FQHC grantee or sub-grantee under the 340B Prescription Drug Program” plus a “minimal” fee.

    From your own link, FQHCs already had a requirement to not charge anything to people in poverty, so “If ‘low income’ is defined as under 100% of poverty, this may not really change anything. Even if the income level is set somewhat higher, most patients likely would still have been protected by the sliding fee scale without this change”.

    This link, like your others, is from 2020. I don’t know how “low income” would actually have been defined since it wasn’t scheduled to come into place until Jan 22nd - during Biden’s administration.

    It’s true that Biden froze this - as others have mentioned in this thread, he put a 60 day freeze on all pending legislature when taking office, which is a fairly standard practice.

    Biden’s own Insulin cap was part of the Inflation Reduction Act, and capped the price of Insulin to $35 monthly for products covered by Medicare D.

    So yeah I concede that it’s an oversimplification to say that Trump did nothing and Biden did everything, but… the Insulin cap is Biden’s legislation. Trump did not cap Insulin or Epipen prices during his 4 years in office.